389 related articles for article (PubMed ID: 33952592)
41. Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
Gill RR; Murphy DJ; Kravets S; Sholl LM; Janne PA; Johnson BE
J Surg Oncol; 2018 Dec; 118(7):1170-1177. PubMed ID: 30261097
[TBL] [Abstract][Full Text] [Related]
42. Determining factors of endobronchial ultrasound-guided transbronchial needle aspiration specimens for lung cancer subtyping and molecular testing.
Zhang Y; Xie F; Mao X; Zheng X; Li Y; Zhu L; Sun J
Endosc Ultrasound; 2019; 8(6):404-411. PubMed ID: 31670289
[TBL] [Abstract][Full Text] [Related]
43. The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt.
Bahnassy AA; Ismail H; Mohanad M; El-Bastawisy A; Yousef HF
J Egypt Natl Canc Inst; 2022 May; 34(1):23. PubMed ID: 35644823
[TBL] [Abstract][Full Text] [Related]
44. Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP).
Salas C; Martín-López J; Martínez-Pozo A; Hernández-Iglesias T; Carcedo D; Ruiz de Alda L; García JF; Rojo F
J Clin Pathol; 2022 Mar; 75(3):193-200. PubMed ID: 33722840
[TBL] [Abstract][Full Text] [Related]
45. Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Hara N; Ichihara E; Harada D; Inoue K; Fujiwara K; Hosokawa S; Kishino D; Haruyuki K; Ochi N; Oda N; Hotta K; Maeda Y; Kiura K
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3749-3755. PubMed ID: 33779840
[TBL] [Abstract][Full Text] [Related]
46. Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer.
Kirita K; Izumo T; Matsumoto Y; Hiraishi Y; Tsuchida T
Lung; 2016 Jun; 194(3):371-8. PubMed ID: 26951235
[TBL] [Abstract][Full Text] [Related]
47. Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping.
Trisolini R; Cancellieri A; Tinelli C; de Biase D; Valentini I; Casadei G; Paioli D; Ferrari F; Gordini G; Patelli M; Tallini G
Chest; 2015 Dec; 148(6):1430-1437. PubMed ID: 26158441
[TBL] [Abstract][Full Text] [Related]
48. False-negative programmed death-ligand 1 immunostaining in ethanol-fixed endobronchial ultrasound-guided transbronchial needle aspiration specimens of non-small-cell lung cancer patients.
Koomen BM; Vreuls W; de Boer M; de Ruiter EJ; Hoelters J; Vink A; Willems SM
Histopathology; 2021 Oct; 79(4):480-490. PubMed ID: 33772818
[TBL] [Abstract][Full Text] [Related]
49. Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.
Guerini-Rocco E; Passaro A; Casadio C; De Luca VM; Guarize J; de Marinis F; Vacirca D; Barberis M
Arch Pathol Lab Med; 2018 Apr; 142(4):465-473. PubMed ID: 29565206
[TBL] [Abstract][Full Text] [Related]
50. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
[TBL] [Abstract][Full Text] [Related]
51. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.
Navani N; Brown JM; Nankivell M; Woolhouse I; Harrison RN; Jeebun V; Munavvar M; Ng BJ; Rassl DM; Falzon M; Kocjan G; Rintoul RC; Nicholson AG; Janes SM
Am J Respir Crit Care Med; 2012 Jun; 185(12):1316-22. PubMed ID: 22505743
[TBL] [Abstract][Full Text] [Related]
52. Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations.
Mei P; Shilo K; Wei L; Shen R; Tonkovich D; Li Z
Cancer Cytopathol; 2019 Jul; 127(7):447-457. PubMed ID: 31025831
[TBL] [Abstract][Full Text] [Related]
53. ALK rearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer.
Neat MJ; Foot NJ; Hicks A; Breen R; Wilkins B; McLean E; Santis G
Cytopathology; 2013 Dec; 24(6):356-64. PubMed ID: 23551582
[TBL] [Abstract][Full Text] [Related]
54. Adequacy of endobronchial ultrasound-guided transbronchial needle aspiration samples processed as histopathological samples for genetic mutation analysis in lung adenocarcinoma.
Jeyabalan A; Bhatt N; Plummeridge MJ; Medford AR
Mol Clin Oncol; 2016 Jan; 4(1):119-125. PubMed ID: 26870369
[TBL] [Abstract][Full Text] [Related]
55. Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer.
van der Heijden EH; Casal RF; Trisolini R; Steinfort DP; Hwangbo B; Nakajima T; Guldhammer-Skov B; Rossi G; Ferretti M; Herth FF; Yung R; Krasnik M;
Respiration; 2014; 88(6):500-17. PubMed ID: 25377908
[TBL] [Abstract][Full Text] [Related]
56. [Diagnostic Value of Transbronchial Ultrasound-guided Needle Aspiration Biopsy in the Diagnosis of Small Cell Lung Cancer and Non-small Cell Lung Cancer].
Tan X; Liu B; Wang R; Zhang Y
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):466-471. PubMed ID: 32517451
[TBL] [Abstract][Full Text] [Related]
57. Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.
Canberk S; Engels M
Virchows Arch; 2021 Jan; 478(1):45-57. PubMed ID: 33389149
[TBL] [Abstract][Full Text] [Related]
58. A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of non-small cell lung cancer cases.
Rooper LM; Nikolskaia O; Carter J; Ning Y; Lin MT; Maleki Z
Hum Pathol; 2016 May; 51():139-45. PubMed ID: 26980023
[TBL] [Abstract][Full Text] [Related]
59. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.
van Eijk R; Licht J; Schrumpf M; Talebian Yazdi M; Ruano D; Forte GI; Nederlof PM; Veselic M; Rabe KF; Annema JT; Smit V; Morreau H; van Wezel T
PLoS One; 2011 Mar; 6(3):e17791. PubMed ID: 21408138
[TBL] [Abstract][Full Text] [Related]
60. A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer.
Tsunoda A; Morikawa K; Inoue T; Miyazawa T; Hoshikawa M; Takagi M; Mineshita M
BMC Cancer; 2019 Jun; 19(1):546. PubMed ID: 31174496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
